688 related articles for article (PubMed ID: 8979178)
1. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
Modanlou HD; Beharry K; Padilla G; Iriye B
J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
[TBL] [Abstract][Full Text] [Related]
2. Antenatal corticosteroid therapy in premature infants.
Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
[TBL] [Abstract][Full Text] [Related]
3. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
[TBL] [Abstract][Full Text] [Related]
5. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M
Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies.
Turrentine MA; Wilson PD; Wilkins IA
Am J Perinatol; 1996 Aug; 13(6):351-4. PubMed ID: 8865981
[TBL] [Abstract][Full Text] [Related]
7. [The corticosteroid therapy of premature rupture of the fetal membranes].
Ruseva R; Dimitrov E; Slŭncheva B; Iarŭkova N
Akush Ginekol (Sofiia); 1999; 38(4):5-7. PubMed ID: 10726340
[TBL] [Abstract][Full Text] [Related]
8. [Importance of pre- and perinatal risk factors in respiratory distress syndrome of premature infants. A logical regression analysis of 1100 cases].
Harms K; Herting E; Kron M; Schill M; Schiffmann H
Z Geburtshilfe Neonatol; 1997; 201(6):258-62. PubMed ID: 9491546
[TBL] [Abstract][Full Text] [Related]
9. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS
Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
[TBL] [Abstract][Full Text] [Related]
10. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
11. Prevention of respiratory distress syndrome: synergistic therapies.
Gross I
Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442
[TBL] [Abstract][Full Text] [Related]
12. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.
Sehdev HM; Abbasi S; Robertson P; Fisher L; Marchiano DA; Gerdes JS; Ludmir J
Am J Obstet Gynecol; 2004 Oct; 191(4):1409-13. PubMed ID: 15507974
[TBL] [Abstract][Full Text] [Related]
13. Survival and outcome of very low birth weight infants born in a university hospital with level II NICU.
Sritipsukho S; Suarod T; Sritipsukho P
J Med Assoc Thai; 2007 Jul; 90(7):1323-9. PubMed ID: 17710972
[TBL] [Abstract][Full Text] [Related]
14. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
[TBL] [Abstract][Full Text] [Related]
15. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
Kinalski M; Sledziewski A; Kretowski A
Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
[TBL] [Abstract][Full Text] [Related]
16. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
Ghaemi S; Mohamadymasodi M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome.
Tsao PN; Wei SC; Chou HC; Su YN; Chen CY; Hsieh FJ; Hsieh WS
Pediatr Pulmonol; 2005 May; 39(5):461-5. PubMed ID: 15786439
[TBL] [Abstract][Full Text] [Related]
20. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
Block MF; Kling OR; Crosby WM
Obstet Gynecol; 1977 Aug; 50(2):186-90. PubMed ID: 327364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
